A study by Zhang et al. (2020) showed that SELENOK expression is significantly decreased in the brains of AD patients and mice and that SELENOK knockout is associated with pathological changes, such as intracellular Ca2+ flux dysregulation in neurons and an imbalance in the distribution of synaptic receptors, that are highly consistent with AD pathology. Here, SELENOK is linked to Alzheimer disease.